Droplet IV here to create better patient outcomes and reduce the burden of nurses by building the futur of IV infusion therapy.
Droplet IV has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
Droplet IV's investors include MedTech Innovator, BioInnovation Institute Venture Lab, BioInnovation Institute Venture House.
Droplet IV is headquartered in Kongens Lyngby, Denmark.
Droplet IV here to create better patient outcomes and reduce the burden of nurses by building the futur of IV infusion therapy.
Droplet IV is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Droplet IV — Funding & Investors." VCBacked, June 17, 2025, https://www.vcbacked.co/company/droplet-iv. Accessed July 23, 2026.
VCBacked. (2025). Droplet IV — Funding & Investors. Retrieved July 23, 2026, from https://www.vcbacked.co/company/droplet-iv
{{cite web |title=Droplet IV — Funding & Investors |url=https://www.vcbacked.co/company/droplet-iv |website=VCBacked |access-date=July 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated